Rocket Lab SEC Filings

Edward H. Frank, a Director at Rocket Lab USA, Inc., acquired 67,589 restricted stock units (RSUs) on September 2, 2022, at $0.00 per share under the company's Non-Employee Director Compensation Policy. This is a standard compensation grant with vesting over three years. The transaction is neutral, as it represents routine director pay rather than a discretionary purchase.

This 424B3 prospectus supplement updates the May 2022 prospectus with a September 6, 2022 8-K reporting the September 2 appointment of Dr. Edward H. Frank as a Class II director. The board size increased from eight to nine, and Frank qualifies as independent with prior roles at Apple and Broadcom. Investors should note the addition of semiconductor and hardware systems expertise to governance.

This 424B3 prospectus supplement updates the May 2022 prospectus with the Sept 6 2022 8-K. It discloses the Sept 2 2022 board expansion from eight to nine directors and appointment of independent director Dr. Edward H. Frank as Class II with term expiring at the 2023 annual meeting. The filing is relevant to investors for governance updates and addition of tech hardware expertise.

This 424B3 prospectus supplement updates the May 2022 S-1 with an 8-K filed September 6, 2022. The 8-K discloses the board size increase from eight to nine directors and the appointment of Dr. Edward H. Frank as Class II director effective September 2, 2022. The filing provides his background, independence confirmation, and standard non-employee director compensation details.

Rocket Lab expanded its Board from eight to nine directors and appointed Dr. Edward H. Frank as a Class II director effective September 2, 2022, with term expiring at the 2023 annual meeting. Dr. Frank, qualified as independent under Nasdaq standards, brings extensive tech leadership from Apple, Broadcom, and startups. Compensation includes prorated cash retainer and $360,000 initial RSU grant vesting over three years per standard policy.

Arjun Kampani, Senior Vice President, General Counsel and Secretary at Rocket Lab USA, sold 14,121 shares of common stock on 08/24/2022 at a weighted average price of $5.25. The sale was a 'sell-to-cover' transaction to satisfy tax withholding obligations upon vesting of restricted stock units. This is a neutral signal as it is routine and non-discretionary.

Chief Financial Officer Adam C. Spice sold 41,508 shares of Rocket Lab USA common stock on 08/24/2022 at a weighted average price of $5.25. The sale was a non-discretionary 'sell-to-cover' transaction to satisfy tax withholding on vesting restricted stock units. This is a neutral signal, as it reflects routine tax management rather than voluntary selling.

This SC 13D/A (Amendment No. 2) reports pro rata distributions of Rocket Lab common stock by Bessemer Venture Partners VIII funds to limited partners on August 24, 2022. Post-distribution, the reporting entities beneficially own 65,165,990 shares (13.9% of outstanding shares). Investors should monitor for further changes in this major shareholder's position.

Bessemer Venture Partners VIII L.P. and affiliates, 10% owners and directors of Rocket Lab USA, disposed of 4,071,241 common shares via pro rata distribution to limited partners on 08/24/2022. The transaction involved no consideration and was exempt under SEC Rules 16a-13 and 16a-9. Signal is neutral as it is routine VC fund housekeeping.

This 424B3 prospectus supplement updates the May 2022 prospectus with the August 11, 2022 10-Q for the quarter ended June 30, 2022. Key facts include revenue of $55.5 million (up 392% YoY), net loss of $37.4 million, $542.5 million cash, and $531.4 million backlog. Relevance to investors is the provision of updated quarterly financials and business updates.